Accretion Pharmaceuticals Live Share Price Today, Share Analysis and Chart

Name: Accretion Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Accretion Pharmaceuticals Ltd.
Rating: 2.04466675
Author: Trendlyne DVM scores

Iran war impact

The impact of the ongoing conflict on Accretion Pharmaceuticals Ltd. (ACCPL) is negative, primarily due to its strategic exposure to the Middle Eastern markets and its reliance on global supply chains for critical pharmaceutical inputs. ### 1...

70.00 3.30 (4.95%)

18,000

NSE Volume

NSE 02 Apr, 2026 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

Not Eligible

Mid Valuation

- / 100

Technically Neutral

46.1 / 100

No estimates available

Accretion Pharmaceuticals Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Accretion Pharmaceuticals Live Share Price Today, Share Analysis and Chart

The impact of the ongoing conflict on Accretion Pharmaceuticals Ltd. (ACCPL) is negative, primarily due to its strategic exposure to the Middle Eastern markets and its reliance on global supply chains for critical pharmaceutical inputs. ### 1...

SWOT Analysis

Accretion Pharmaceuticals Live Price Chart